Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Lymphoma, Large B-Cell, Diffuse 416Lymphoma 406Lymphoma, Non-Hodgkin 344Leukemia, Lymphocytic, Chronic, B-Cell 313Lymphoma, Follicular 301Lymphoma, Mantle-Cell 226Lymphoma, B-Cell, Marginal Zone 161Lymphoma, B-Cell 112Leukemia 112Burkitt Lymphoma 110Waldenstrom Macroglobulinemia 99Precursor Cell Lymphoblastic Leukemia-Lymphoma 90Recurrence 82Hodgkin Disease 60Lymphoma, Large-Cell, Immunoblastic 57Neoplasms 33Lymphoma, Large-Cell, Anaplastic 26Myelodysplastic Syndromes 24Leukemia, Myeloid, Acute 24Multiple Myeloma 21Dendritic Cell Sarcoma, Interdigitating 19Intraocular Lymphoma 17Leukemia, Prolymphocytic 15Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 14Lymphoma, T-Cell 14Hematologic Neoplasms 13Lymphoproliferative Disorders 12Leukemia, Hairy Cell 11Leukemia, B-Cell 11Hematologic Diseases 11

Interventions

glucarpidase 2safinamide 1sacubitril and valsartan sodium hydrate drug combination 1ripretinib 1mirabegron 1gamma-Glutamyl Hydrolase 1Sitagliptin Phosphate 1Rituximab 1Methotrexate 1Leucovorin 1Lenalidomide 1Eplerenone 1Duration of Therapy 1Cyclophosphamide 1Cilengitide 1Carboxypeptidases 1Bendamustine Hydrochloride 1Azacitidine 13-(5-amino-2-methyl-4-oxoquinazolin-3(4H)-yl)piperidine-2,6-dione 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Renal Insufficiency × Rituximab × Lymphoid × Clear all
NCT01832922 2018-03-30

BR in Patients With CLL With Comorbidities and/or Renal Dysfunction

Dartmouth-Hitchcock Medical Center

Phase 1 Completed
8 enrolled
LymphoidOther hematologic neoplasm

Leukemia, Lymphocytic, Chronic, B-Cell, Renal Insufficiency

Data powered by HemOnc (CC BY 4.0) Colophon âš¡